Pharmacological use of glucocorticoid receptor agonists, coupled with judicious administration times in an asthma model, were shown to minimize phase shifting in the expression of key clock genes, and thus of their clock-dependent proteins [58], providing an avenue to couple DS to circadian control of MC activity. This evidence concerns the gene CLOCK and asthma.